Skip to content

Faculty profile

ResearcherEndocrinology and MetabolismMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes.

    Diabetes care · 2025

  • Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.

    BMJ (Clinical research ed.) · 2024

  • Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes.

    Diabetes care · 2022

All 7 publications

Latest funding

  • Use of ultra-long-acting insulin versus long-acting insulin in the management of type 2 diabetes and the risk of adverse renal outcomes among people with diabetic kidney disease

    CIHR · 2026 · Co-investigator

    $497,250
  • GLP-1 Receptor Agonists in Older Adults: Weighing Cardiovascular Benefits Against Frailty-Related Risks

    CIHR · 2025 · Co-investigator

    $397,800
  • Assessing the long-term carcinogenic effects of glucagon-like peptide-1 receptor agonists on thyroid, pancreatic, and biliary tract cancers: an international, multi-site cohort study

    CIHR · 2024 · Co-investigator

    $294,526
All 16 grants and awards
Something wrong or missing on this profile? Suggest a correction